Medrad/Bayer Introduces Mark 7 Arterion Angiographic Contrast Injector

 

April 4, 2012

April 4, 2012 — Medrad (Bayer) recently introduced the Mark 7 Arterion angiographic contrast injection system. The system is much smaller, lighter-weight, more ergonomic and easier to maneuver than previous Medrad injectors. It also is easier to operate than previous models, requiring less time to position and set up. It has a clearly visible and intuitive user interface to guide the user through proper set-up, and highlights the information need to perform injections.

The Mark 7 Arterion has a unique front loading system to simplify set-up and makes for a cleaner tear down. The Mark 7 Arterion syringe provides a clear view of the contrast. 

For more information: www.medrad.com

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.